Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
Wollenberg A, Nakahara T, Maari C, Peris K, Lio P, Augustin M, Silverberg JI, Rueda MJ, DeLozier AM, Pierce E, Yang FE, Sun L, Ball S, Tauber M, Paul C. Wollenberg A, et al. Among authors: paul c. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1543-1552. doi: 10.1111/jdv.17278. Epub 2021 Jun 5. J Eur Acad Dermatol Venereol. 2021. PMID: 33834521 Free PMC article. Clinical Trial.
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
Wolff K, Fleming C, Hanifin J, Papp K, Reitamo S, Rustin M, Shear N, Silny W, Korman N, Marks I, Cherill R, Emady-Azar S, Paul C; Multicentre Investigator Group. Wolff K, et al. Among authors: paul c. Br J Dermatol. 2005 Jun;152(6):1296-303. doi: 10.1111/j.1365-2133.2005.06674.x. Br J Dermatol. 2005. PMID: 15948996 Clinical Trial.
Moderate to severe psoriasis: from topical to biological treatment.
Gardinal I, Ammoury A, Paul C. Gardinal I, et al. Among authors: paul c. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1324-6. doi: 10.1111/j.1468-3083.2009.03216.x. Epub 2009 Mar 11. J Eur Acad Dermatol Venereol. 2009. PMID: 19470061
Psoriasis: an epidemiological evaluation of disease burden in 590 patients.
Meyer N, Paul C, Feneron D, Bardoulat I, Thiriet C, Camara C, Sid-Mohand D, Le Pen C, Ortonne JP. Meyer N, et al. Among authors: paul c. J Eur Acad Dermatol Venereol. 2010 Sep;24(9):1075-82. doi: 10.1111/j.1468-3083.2010.03600.x. Epub 2010 Mar 4. J Eur Acad Dermatol Venereol. 2010. PMID: 20236205
Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists.
Paul C, Gourraud PA, Bronsard V, Prey S, Puzenat E, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. Paul C, et al. J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:2-9. doi: 10.1111/j.1468-3083.2009.03561.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20443994 Review.
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
Puzenat E, Bronsard V, Prey S, Gourraud PA, Aractingi S, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Paul C, Richard-Lallemand MA, Ortonne JP, Aubin F. Puzenat E, et al. Among authors: paul c. J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:10-6. doi: 10.1111/j.1468-3083.2009.03562.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20443995 Review.
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.
Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. Bronsard V, et al. Among authors: paul c. J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:17-22. doi: 10.1111/j.1468-3083.2009.03563.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20443996 Review.
2,208 results